A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: In patients undergoing off-pump coronary artery bypass (OPCAB) surgery, does the off-pump to on-pump conversion rate have an impact on post-operative results? Altogether more than 420 papers were found using the reported search, of which 14 randomized controlled trials (RCTs) represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated and ordered according to the sample size. In the 14 RCTs reviewed, the off-pump to on-pump conversion rate incidence ranged from 0 to 13.3%. The most frequent causes of conversion were haemodynamic instability and intramyocardial-coronary target. A low conversion rate (<2%) was reported by five studies. Three of them did not show any difference in terms of mortality between the OPCAB and on-pump groups, one showed better survival of the OPCAB group at 5 years, and one reported better early survival of the OPCAB group. Three of these trials describe a high OPCAB experience and reported that patients undergoing OPCAB had a shorter post-operative stay and lower morbidity compared with patients undergoing on-pump coronary artery bypass grafting. Five RCTs showed a high conversion rate (>9%), and among them, one reported lower morbidity of the OPCAB patients, three were not able to show any benefit in terms of morbidity of the OPCAB, and one reported worse survival and patency graft rate of the OPCAB group. Four RCTs reported conversion rates ranging from 3.7 to 7.0%, describing a wide spectrum of results. We conclude that RCTs with a high off-pump to on-pump conversion rate were often associated with a lower experience in OPCAB of the surgeons participating in the trials. These studies were also mostly unable to show any benefit in terms of mortality or morbidity of OPCAB over the on-pump strategy. On the contrary, a low conversion rate is mostly reported by RCTs with a high structured experience in OPCAB. These trials were mostly able to show a benefit, in terms of morbidity and survival, of the OPCAB over the on-pump strategy.
INTRODUCTION
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS [1] . 
THREE-PART QUESTION
In
CLINICAL SCENARIO
After starting your OPCAB programme, one of the referring cardiologists at your hospital suggests you abort your project because of the bad results reported by the ROOBY trial in terms of survival. You want to check the literature for evidence on this issue.
SEARCH STRATEGY
The MEDLINE database was searched from January 1966 to May 2011. The medical subject headings keywords included OPCAB, off-pump, off-pump, beating heart. Only randomized clinical trials with a sample population of 100 or more patients were included in this review. Early overall mortality in on-pump group was almost double than in off-pump group with no statistical difference The number of patients with myocardial infarction was nearly doubled in the on-pump group (15 versus 9) with no statistical difference The mean number of grafts per patient did not differ significantly between the groups (3.22 in off-pump group and 3.34 in on-pump group; P = 0.11). Fewer grafts were performed to the lateral part of the left ventricle territory during off-pump surgery (0.97 versus 1.14 after on-pump surgery; P = 0.01)
Off-pump to on-pump conversion rate 
Continued

RESULTS
In the 14 randomized controlled trials (RCTs) reviewed, the off-pump to on-pump conversion rate ranged from 0 to 13.3%. The most frequent causes of conversion were haemodynamic instability and intramyocardial-coronary target.
A low conversion rate (<2%) was reported by five studies: the BACHAS trials [2] , the Smart trial [3] , the Mass III [4] , the study published by Fattouch et al. [5] and the study published by Hernandez et al. [6] . The first three of them (BACHAS trials [2] , Smart trial [3] and Mass III [4] ) describe a high structured experience in OPCAB. In the remaining Graft-patency rate was lower at 3 months in the off-pump group than in the on-pump group Off-pump to on-pump conversion rate 3.7% Causes: electrical instability (n = 1) and intramyocardial LAD (n = 1)
Experience in OPCAB 'In the two years preceding the study, the surgeons performed 13% of their coronary work off-pump'
studies [3, [6] [7] [8] [9] [10] , no data about experience in off-pump are available. Among these five RCTs, three [2, 4, 6] did not show any difference in terms of early, mid-or long-term mortality between the OPCAB and on-pump groups, one showed better survival of the OPCAB group at 5 years [3] , and one [10] reported a lower early mortality in patients with ST-segment elevation myocardial infarction undergoing OPCAB in comparison to the on-pump group. Three RCTs described lower post-operative morbidity (rate of atrial fibrillation, chest infection, transfusion of red blood, inotropic requirement [2] , stroke [6] ) and lower hospital stay [2, 3] in patients undergoing OPCAB).
Both studies analysing the bypasses functionality (BACHAS trials [2] , Smart trial [3] ) reported no differences in long-term graft patency.
Five RCTs presented a high conversion rate (>9%): the ROOBY Trial [5] , the Prague-4 Trial [11] , and the studies published by Legare et al. [12] , Muneretto et al. [9] , and Lingass et al. [13] . Among them, the ROOBY Trial [5] is the largest RCT (2203 patients), the one documenting the poorest experience in OPCAB by the surgeons participating in the trial, and the one associated with the second highest conversion rate (12.4%).
Among this group of RCTs only the ROOBY Trial [5] documented a worse early survival of the OPCAB group. None, except one [5] , documented a benefit in term of reduction of the morbidity in the OPCAB group.
Among the 3 trials exploring graft patency [5, 11, 13] only the ROOBY trial [5] showed a lower overall rate of graft patency of the OPCAB group.
Four RCTs showed an intermediate conversion rate, ranging from 3.7 to 7.0%: the Best Bypass Surgery Trial [14] , Octopus trial [15] and the studies published by Masoumi et al. [16] and Khan et al. [17] .
In this group, only the Best Bypass Surgery Trial [14] reported a high experience in OPCAB of the surgeons participating in the trial.
The Best Bypass Surgery Trial, which is also the largest study of this group (341 patients), showed that the on-pump early overall mortality and incidence of myocardial infarction nearly doubled those of the off-pump group (no statistical significant in both cases). It also showed no differences in terms of graft numbers between the two groups.
The Octopus trial [15] reported no difference with regards to cardiac outcomes and early survival and quality of life between the OPCAB and on pump groups.
Masoumi et al. [16] have analysed only patients with severe left ventricle dysfunction. This trial was able to show lower mortality, low cardiac output events, arrhythmias, renal failure and gastrointestinal haemorrhage in the off-pump group compared with the on-pump group.
Khan et al. [17] showed a lower graft-patency rate at 3 months in the off-pump group than in the on-pump group.
CLINICAL BOTTOM LINE
We conclude that RCTs with a high off-pump to on-pump conversion rate (>9%) were often associated with a low experience in OPCAB of the surgeons participating in the trials. These studies were also mostly not able to show any benefit in terms of mortality or morbidity of OPCAB over the on-pump strategy.
On the contrary, a low conversion rate (<2%) is mostly reported by RCTs with a high structured experience in OPCAB. These trials were mostly able to show a benefit in terms of morbidity, and in two cases of survival, of the OPCAB over the on-pump strategy. No trials with a low conversion rate were able to document a significant difference in terms of graft patency between the on-pump and the OPCAB groups.
RCTs with an intermediate conversion rate reported a wide spectrum of results.
The results of this review may be jeopardized by the fact that the outcomes of the trials included were strongly influenced by their statistical power.
